Literature DB >> 15580732

Preventing congenital toxoplasmosis.

A Lopez1, V J Dietz, M Wilson, T R Navin, J L Jones.   

Abstract

SCOPE OF THE PROBLEM: Toxoplasmosis is caused by infection with the protozoan parasite Toxoplasma gondii. Acute infections in pregnant women can be transmitted to the fetus and cause severe illness (e.g., mental retardation, blindness, and epilepsy). An estimated 400-4,000 cases of congenital toxoplasmosis occur each year in the United States. Of the 750 deaths attributed to toxoplasmosis each year, 375 (50%) are believed to be caused by eating contaminated meat, making toxoplasmosis the third leading cause of foodborne deaths in this country. ETIOLOGIC FACTORS: Toxoplasma can be transmitted to humans by three principal routes: a) ingestion of raw or inadequately cooked infected meat; b) ingestion of oocysts, an environmentally resistant form of the organism that cats pass in their feces, with exposure of humans occurring through exposure to cat litter or soil (e.g., from gardening or unwashed fruits or vegetables); and c) a newly infected pregnant woman passing the infection to her unborn fetus. RECOMMENDATIONSFOR PREVENTION: Toxoplasma infection can be prevented in large part by a) cooking meat to a safe temperature (i.e., one sufficient to kill Toxoplasma); b) peeling or thoroughly washing fruits and vegetables before eating; c) cleaning cooking surfaces and utensils afterthey have contacted raw meat, poultry, seafood, or unwashed fruits or vegetables; d) pregnant women avoiding changing cat litter or, if no one else is available to change the cat litter, using gloves, then washing hands thoroughly; and e) not feeding raw or undercooked meat to cats and keeping cats inside to prevent acquisition of Toxoplasma by eating infected prey. RESEARCH AGENDA: Priorities for research were discussed at a national workshop sponsored by CDC in September 1998 and include a) improving estimates of the burden of toxoplasmosis, b) improving diagnostic tests to determine when a person becomes infected with Toxoplasma, and c) determining the applicability of national screening programs.
CONCLUSION: Many cases of congenital toxoplasmosis can be prevented. Specific measures can be taken by women and their health-care providers to decrease the risk for infection during pregnancy and prevent severe illness in newborn infants.

Entities:  

Mesh:

Year:  2000        PMID: 15580732

Source DB:  PubMed          Journal:  MMWR Recomm Rep        ISSN: 1057-5987


  31 in total

1.  Preventive behavior for toxoplasmosis in pregnant adolescents in the state of Ceara, Brazil.

Authors:  Fabianne Ferreira Costa; Ana Paula Soares Gondim; Mary Braga de Lima; Jose Ueleres Braga; Luiza Jane Eyre de Souza Vieira; Maria Alix Leite Araújo
Journal:  BMC Public Health       Date:  2012-01-24       Impact factor: 3.295

2.  Toxoplasmosis during pregnancy.

Authors:  Ariel Many; Gideon Koren
Journal:  Can Fam Physician       Date:  2006-01       Impact factor: 3.275

3.  Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective.

Authors:  Marcie Tomblyn; Tom Chiller; Hermann Einsele; Ronald Gress; Kent Sepkowitz; Jan Storek; John R Wingard; Jo-Anne H Young; Michael J Boeckh; Michael A Boeckh
Journal:  Biol Blood Marrow Transplant       Date:  2009-10       Impact factor: 5.742

4.  Estimates of the burden of foodborne illness in Canada for 30 specified pathogens and unspecified agents, circa 2006.

Authors:  M Kate Thomas; Regan Murray; Logan Flockhart; Katarina Pintar; Frank Pollari; Aamir Fazil; Andrea Nesbitt; Barbara Marshall
Journal:  Foodborne Pathog Dis       Date:  2013-05-09       Impact factor: 3.171

5.  Sero-epidemiology and risk factors for Toxoplasma gondii among pregnant women in Arab and African countries.

Authors:  Mohamed Alkhatim Alsammani
Journal:  J Parasit Dis       Date:  2014-09-20

6.  Anti-Toxoplasma antibody prevalence, primary infection rate, and risk factors in a study of toxoplasmosis in 4,466 pregnant women in Japan.

Authors:  Makiko Sakikawa; Shunichi Noda; Masachi Hanaoka; Hirotoshi Nakayama; Satoshi Hojo; Shigeko Kakinoki; Maki Nakata; Takashi Yasuda; Tsuyomu Ikenoue; Toshiyuki Kojima
Journal:  Clin Vaccine Immunol       Date:  2011-12-28

Review 7.  The impact of the waterborne transmission of Toxoplasma gondii and analysis efforts for water detection: an overview and update.

Authors:  Panagiotis Karanis; Hebatalla M Aldeyarbi; Marzieh E Mirhashemi; Khalil M Khalil
Journal:  Environ Sci Pollut Res Int       Date:  2012-09-19       Impact factor: 4.223

8.  Annual burden of ocular toxoplasmosis in the US.

Authors:  Jeffrey L Jones; Gary N Holland
Journal:  Am J Trop Med Hyg       Date:  2010-03       Impact factor: 2.345

9.  Toxoplasma gondii seroprevalence in the United States 2009-2010 and comparison with the past two decades.

Authors:  Jeffrey L Jones; Deanna Kruszon-Moran; Hilda N Rivera; Courtney Price; Patricia P Wilkins
Journal:  Am J Trop Med Hyg       Date:  2014-04-07       Impact factor: 2.345

10.  Otopathology in congenital toxoplasmosis.

Authors:  Mehti Salviz; Jose G Montoya; Joseph B Nadol; Felipe Santos
Journal:  Otol Neurotol       Date:  2013-08       Impact factor: 2.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.